Baillie Gifford & CO Hutchmed (China) LTD Transaction History

Baillie Gifford & CO

  • $126 Billion
  • Q2 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024
BUY
$16.25 - $20.23 $157,527 - $196,109
9,694 Added 7.17%
144,969 $2.63 Million
Q3 2023

Nov 13, 2023
SELL
$11.85 - $16.95 $85,320 - $122,040
-7,200 Reduced 5.05%
135,275 $2.29 Million
Q2 2023

Jul 28, 2023
SELL
$10.78 - $17.73 $105,105 - $172,867
-9,750 Reduced 6.4%
142,475 $1.71 Million
Q4 2022

Jan 24, 2023
SELL
$7.65 - $15.51 $1.82 Million - $3.69 Million
-237,593 Reduced 60.95%
152,225 $2.25 Million
Q3 2022

Oct 27, 2022
BUY
$8.63 - $15.52 $214,360 - $385,501
24,839 Added 6.81%
389,818 $3.45 Million
Q2 2022

Aug 08, 2022
SELL
$8.59 - $20.77 $6,983 - $16,886
-813 Reduced 0.22%
364,979 $4.61 Million
Q1 2022

May 05, 2022
BUY
$15.52 - $35.65 $26,756 - $61,460
1,724 Added 0.47%
365,792 $6.92 Million
Q4 2021

Jan 20, 2022
SELL
$28.89 - $35.33 $112,584 - $137,681
-3,897 Reduced 1.06%
364,068 $12.8 Million
Q3 2021

Oct 19, 2021
BUY
$35.66 - $42.94 $25,211 - $30,358
707 Added 0.19%
367,965 $13.5 Million
Q2 2021

Aug 02, 2021
BUY
$23.7 - $39.27 $1.05 Million - $1.73 Million
44,105 Added 13.65%
367,258 $14.4 Million
Q1 2021

May 06, 2021
BUY
$27.01 - $36.8 $786,801 - $1.07 Million
29,130 Added 9.91%
323,153 $9.13 Million
Q4 2020

Feb 10, 2021
BUY
$27.51 - $34.36 $616,664 - $770,213
22,416 Added 8.25%
294,023 $9.41 Million
Q3 2020

Nov 12, 2020
BUY
$25.8 - $34.61 $1.15 Million - $1.54 Million
44,567 Added 19.63%
271,607 $8.77 Million
Q2 2020

Aug 12, 2020
BUY
$17.65 - $28.05 $131,227 - $208,551
7,435 Added 3.39%
227,040 $6.26 Million
Q1 2020

May 08, 2020
BUY
$15.19 - $29.51 $25,731 - $49,989
1,694 Added 0.78%
219,605 $3.92 Million
Q2 2019

Aug 08, 2019
SELL
$22.0 - $31.78 $65,670 - $94,863
-2,985 Reduced 1.35%
217,911 $4.79 Million
Q1 2019

May 01, 2019
BUY
$21.27 - $30.58 $466,599 - $670,833
21,937 Added 11.03%
220,896 $0
Q4 2018

Feb 14, 2019
BUY
$23.09 - $37.69 $28,008 - $45,717
1,213 Added 0.61%
198,959 $4.59 Million
Q3 2018

Nov 13, 2018
SELL
$26.55 - $34.38 $183,646 - $237,806
-6,917 Reduced 3.38%
197,746 $6.37 Million
Q2 2018

Jul 17, 2018
SELL
$27.79 - $34.49 $41,045 - $50,941
-1,477 Reduced 0.72%
204,663 $6.17 Million
Q1 2018

May 10, 2018
SELL
$28.87 - $41.13 $9,065 - $12,914
-314 Reduced 0.15%
206,140 $6.09 Million
Q4 2017

Feb 13, 2018
BUY
$27.41 - $39.42 $571,498 - $821,907
20,850 Added 11.23%
206,454 $8.14 Million
Q3 2017

Oct 20, 2017
BUY
$22.15 - $27.5 $399,962 - $496,567
18,057 Added 10.78%
185,604 $5.06 Million
Q2 2017

Aug 10, 2017
BUY
N/A
167,547
167,547 $3.91 Million

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email